Patent application number | Description | Published |
20120022831 | METHOD AND TOOLING FOR CONFIGURING A NETWORK OF UNATTENDED GROUND WIRELESS SENSORS - The method for configuring a network of deposited wireless sensors. In certain aspects, these methods include defining performance criteria forming constraints, with associated threshold values, and at least one performance criterion to be optimized, for at least one zone to be equipped with nodes, each performance criterion being defined by a model; defining for said or each zone; the allocation to said or each zone to be equipped, a number of nodes; applying an optimization process per zone on said or each zone; increasing the number of nodes or modifying the performance criteria defined in said or each zone where the performance criteria are not met and reproducing in these zones the optimization process per zone with the new number of nodes or the new performance criteria, and applying the configuration determined at each node in said or each zone. | 01-26-2012 |
20130130615 | METHOD AND SYSTEM FOR DISTRIBUTING CONTENT WITH GUARANTEES OF DELIVERY TIMESCALES IN HYBRID RADIO NETWORKS - Method for disseminating messages or information content in a hybrid network including a network scaffold comprising pilot entities, and a mobile network including mobile nodes communicating in an “ad hoc” manner with one another, the method including: at the level of each of the pilot entities of the scaffold of the network, scheduling the transfers of at least one message by: let S | 05-23-2013 |
20140098708 | METHOD AND TOOLING FOR CONFIGURING A NETWORK OF UNATTENDED GROUND WIRELESS SENSORS - The method for configuring a network of deposited wireless sensors. In certain aspects, these methods include defining performance criteria forming constraints, with associated threshold values, and at least one performance criterion to be optimized, for at least one zone to be equipped with nodes, each performance criterion being defined by a model; defining for said or each zone; the allocation to said or each zone to be equipped, a number of nodes; applying an optimization process per zone on said or each zone; increasing the number of nodes or modifying the performance criteria defined in said or each zone where the performance criteria are not met and reproducing in these zones the optimization process per zone with the new number of nodes or the new performance criteria, and applying the configuration determined at each node in said or each zone. | 04-10-2014 |
Patent application number | Description | Published |
20090117641 | Mutated Abl Kinase Domains - The present invention relates to isolated polypeptides which comprise a functional kinase domain comprising the amino acid sequence of the native human Abl kinase domain or an essentially similar sequence thereof in which at least one amino acid selected from Met244, Leu248, Gly250, Glu252, Tyr253, Val256, Glu258, Phe311, Ile313, Phe317, Met318, Met351, Glu355, Glu359, Ile360, His361, Leu370, Asp381, Phe382, His396, Ser417, Glu459 and Phe486 is replaced by another amino acid, said mutated functional kinase domain being resistant to inhibition of its tyrosine kinase activity by N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-(4-methyl-piperazin-1-ylmethyl)-benzamide or a salt thereof, to the use of such polypeptides to screen for compounds which inhibit the tyrosine kinase activity of such polypeptides, to nucleic acid molecules encoding such polypeptides, to recombinant vectors and host cells comprising such nucleic acid molecules and to the use of such nucleic acid molecules in the production of such polypeptides for use in screening for compounds which inhibit the tyrosine kinase activity of such polypeptides. | 05-07-2009 |
20100021921 | MUTATED ABL KINASE DOMAINS - The present invention relates to isolated polypeptides which comprise a functional kinase domain comprising the amino acid sequence of the native human Abl kinase domain or an essentially similar sequence thereof in which at least one amino acid selected from Met244, Leu248, Gly250, Glu252, Tyr253, Val256, Glu258, Phe311, Ile313, Phe317, Met318, Met351, Glu355, Glu359, Ile360, His361, Leu370, Asp381, Phe382, His396, Ser417, Glu459 and Phe486 is replaced by another amino acid, said mutated functional kinase domain being resistant to inhibition of its tyrosine kinase activity by N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-(4-methyl-piperazin-1-ylmethyl)-benzamide or a salt thereof, to the use of such polypeptides to screen for compounds which inhibit the tyrosine kinase activity of such polypeptides, to nucleic acid molecules encoding such polypeptides, to recombinant vectors and host cells comprising such nucleic acid molecules and to the use of such nucleic acid molecules in the production of such polypeptides for use in screening for compounds which inhibit the tyrosine kinase activity of such polypeptides. | 01-28-2010 |
Patent application number | Description | Published |
20100021920 | MUTATED ABL KINASE DOMAINS - The present invention relates to isolated polypeptides which comprise a functional kinase domain comprising the amino acid sequence of the native human Abl kinase domain or an essentially similar sequence thereof in which at least one amino acid selected from Met244, Leu248, Gly250, Glu252, Tyr253, Val256, Glu258, Phe311, Ile313, Phe317, Met318, Met351, Glu355, Glu359, Ile360, His361, Leu370, Asp381, Phe382, His396, Ser417, Glu459 and Phe486 is replaced by another amino acid, said mutated functional kinase domain being resistant to inhibition of its tyrosine kinase activity by N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-(4-methyl-piperazin-1-ylmethyl)-benzamide or a salt thereof, to the use of such polypeptides to screen for compounds which inhibit the tyrosine kinase activity of such polypeptides, to nucleic acid molecules encoding such polypeptides, to recombinant vectors and host cells comprising such nucleic acid molecules and to the use of such nucleic acid molecules in the production of such polypeptides for use in screening for compounds which inhibit the tyrosine kinase activity of such polypeptides. | 01-28-2010 |